
Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1
Keywords: HCC, hepatocellular carcinoma; miRNA, microRNA; miR-182, microRNA-182; TP53INP1, tumor protein 53-induced nuclear protein1; MTT, 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide; HepG2-R, cisplatin-resistant HepG2 cell linemiR-182; HCC; TP53INP